Lv1
40 积分 2023-06-27 加入
Modeling adenoma–carcinoma progression from a single MLH1-knockout cell via colon organoids
5个月前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
6个月前
已完结
Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation
7个月前
已完结
皖公网安备34019202002308
